Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T19:00:51.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of the clinical trial study, including the addition of detailed classifications of hepatocellular carcinoma and the revision of the study version number. Notably, the previous detailed objectives and treatment protocols have been removed.
    Difference
    40%
    Check dated 2025-04-16T13:16:34.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.
    Difference
    0.4%
    Check dated 2025-04-09T05:55:05.000Z thumbnail image
  5. Check
    66 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing several past dates and adding new future dates, indicating a shift in the timeline of events or updates.
    Difference
    1%
    Check dated 2025-03-03T23:10:49.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:22:17.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:40:48.000Z thumbnail image

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.